Pharmatalkradio
Clinical update on AMG 420, an anti-BCMA BiTE®
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:24:00
- Mais informações
Informações:
Sinopse
In this talk, recorded at the 5th annual IO360° Summit, Dr Alex Minella, Amgen, provides a clinical update on AMG 420, an anti-BCMA BiTE® This talk addresses the: Summary of IND enabling preclinical studiesFirst-in-human trial designFirst-in-human trial data (safety, efficacy) Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com